Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinomaCheng-Lung Hsu, Hsin-Pai Li, Yin‐Kai Chao et al.|Journal of Experimental & Clinical Cancer Research|2018Cited by 36
Additional file 4: of Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinomaCheng‐Lung Hsu, Hsin-Pai Li, Kar‐Wai Lui et al.|Figshare|2018Cited by 0